StockData
Pfizer Inc logo

Pfizer Inc

PFENYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Nov 3, 2026Score 10/3053% above fair value
$30.67+0.15 (+0.49%)

Close on Nov 2, 2026Market cap $174.81BP/E 40.4Yield 5.61%

Pfizer FSME-IMMUN / TicoVac by Year

FSME-IMMUN / TicoVac (tick-borne encephalitis vaccine) — Worldwide operational (constant-currency) YoY (%) (%)

QuarterlyAnnual

Pfizer FSME-IMMUN / TicoVac: 10.0% in FY2025, up 5.0 pts from a year earlier.

Latest, FY2025
10.0%
Period ended Dec 31, 2025
Change on a year earlier
+5.0 pts
5.0% in FY2024
History
9 years
Since FY2017
Sources
9
Documents cited below

Where the FY2025 figure comes from

“|| FSME-IMMUN/TicoVac | 319 | 280 | 14% | 10% | 3 | 3 | 13% | 316 | 277 | 14% | 10%”

Source: Form 8-K (Earnings / Guidance Release) (pfe-12312025xex99.htm, filed 2026-02-03) ↗

Reported in Form 8-K Revenue Tables.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedFSME-IMMUN / TicoVac (tick-borne encephalitis vaccine) — Worldwide operational (constant-currency) YoY (%) (%)Year on yearSource
FY2025Dec 31, 202510.0%+5.0 ptsForm 8-K (Earnings / Guidance Release) (pfe-12312025xex99.htm, filed 2026-02-03) ↗
FY2024Dec 31, 20245.0%-30.0 ptsForm 8-K (Earnings / Guidance Release) (pfe-12312024xex99.htm, filed 2025-02-04) ↗
FY2023Dec 31, 202335.0%+18.0 ptsForm 8-K (Earnings / Guidance Release) (pfe-12312023xex99.htm, filed 2024-01-30) ↗
FY2022Dec 31, 202217.0%+30.0 ptsForm 8-K (Earnings / Guidance Release) (pfe-12312022xex99.htm, filed 2023-01-31) ↗
FY2021Dec 31, 2021-13.0%0.0 ptsForm 8-K (Earnings / Guidance Release) (pfe-12312021xex99.htm, filed 2022-02-08) ↗
FY2020Dec 31, 2020-13.0%-40.0 ptsForm 8-K (Earnings / Guidance Release) (pfe-12312020xex99.htm, filed 2021-02-02) ↗
FY2019Dec 31, 201927.0%-1.0 ptsForm 8-K (Earnings / Guidance Release) (pfe-12312019xex99.htm, filed 2020-01-28) ↗
FY2018Dec 31, 201828.0%+9.0 ptsForm 8-K (Earnings / Guidance Release) (pfe-12312018xex99.htm, filed 2019-01-29) ↗
FY2017Dec 31, 201719.0%–Form 8-K (Earnings / Guidance Release) (pfe-12312017xex99.htm, filed 2018-01-30) ↗

Cite this data

StockData. (2026). Pfizer FSME-IMMUN / TicoVac (%), annual FY2017–FY2025 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/fsme-oper-ww

See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.

See a number that looks wrong?